{"id":1710,"date":"2020-08-07T00:04:36","date_gmt":"2020-08-07T00:04:36","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1710"},"modified":"2023-08-29T17:46:27","modified_gmt":"2023-08-29T17:46:27","slug":"asx-biotech-stocks-benefiting-from-covid-19","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1710","title":{"rendered":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca"},"content":{"rendered":"

\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002<\/p>\n

\u81ea\u7136\u5730\uff0c\u90a3\u4e9b\u4e0e\u6297\u51fb\u6216\u68c0\u6d4b\u75c5\u6bd2(\u4e0d\u7ba1\u662f\u5047\u7684\u8fd8\u662f\u5047\u7684)\u6709\u5173\u7684\u751f\u7269\u6280\u672f\u516c\u53f8\u7684\u4f30\u503c\u98d9\u5347\u3002<\/p>\n

\u6295\u8d44\u8005\u7684\u5174\u8da3\u5e76\u4e0d\u5c40\u9650\u4e8e\u201c\u65b0\u51a0\u96c6\u7fa4\u201d\uff0c\u8be5\u884c\u4e1a\u7684\u878d\u8d44\u83b7\u5f97\u4e86\u5168\u9762\u652f\u6301\u3002<\/p>\n

\u8bca\u65ad\u6d4b\u8bd5\u5e02\u573a<\/h2>\n

\u5728\u8bc4\u4f30\u65b9\u9762\uff0c\u4e00\u4e2a\u503c\u5f97\u6ce8\u610f\u7684\u8d62\u5bb6\u662fGenetic Signatures (ASX: GSS)<\/a>\uff0c\u8be5\u516c\u53f8\u9500\u552e\u9488\u5bf9\u7ec6\u83cc\u548c\u75c5\u6bd2\u72b6\u51b5\u7684\u5206\u5b50\u8bca\u65ad\u6d4b\u8bd5\uff0c\u5305\u62ec\u8d85\u7ea7\u7ec6\u83cc\u3001\u6027\u4f20\u64ad\u75be\u75c5\u548c\u8bfa\u5982\u75c5\u6bd2(\u5728\u51a0\u72b6\u75c5\u6bd2\u767b\u4e0a\u90ae\u8f6e\u4e4b\u524d\uff0c\u8bfa\u5982\u75c5\u6bd2\u662f\u90ae\u8f6e\u4e0a\u7684\u5934\u53f7\u761f\u75ab)\u3002<\/p>\n

\u8fd9\u79cd\u8bd5\u5242\u76d2\u4ee5Easyscreen\u54c1\u724c\u51fa\u552e\uff0c\u53ef\u4ee5\u5728\u5927\u91cf\u60c5\u51b5\u4e0b\u8fdb\u884c\u5feb\u901f\u3001\u51c6\u786e\u7684\u68c0\u6d4b\u3002\u8fd9\u4e9b\u6d4b\u8bd5\u83b7\u53d6\u76ee\u6807\u751f\u7269\u7684\u9057\u4f20\u4fe1\u606f\uff0c\u5e76\u6539\u53d8\u57fa\u56e0\u5e8f\u5217\u4ee5\u51cf\u5c11\u53d8\u91cf\u7684\u6570\u91cf\u3002<\/p>\n

\u800c\u4e14\uff0c\u662f\u7684\uff0c\u8be5\u516c\u53f8\u4e5f\u662f\u4e00\u4e2a\u65b0\u51a0\u7684\u6545\u4e8b\u3002\u5728\u75ab\u60c5\u7206\u53d1\u4e4b\u524d\uff0c\u8be5\u516c\u53f8\u7684Easyscreen\u6d4b\u8bd5\u65e0\u6cd5\u533a\u5206SARS-cov-2(\u5bfc\u81f4\u65b0\u51a0\u75c5\u6bd2\u7684\u75c5\u6bd2)\u548c\u4e25\u91cd\u6025\u6027\u547c\u5438\u7cfb\u7edf\u7efc\u5408\u75c7(SARS)\uff0c\u4f46\u8be5\u516c\u53f8\u5df2\u7ecf\u8bbe\u8ba1\u4e86\u4e00\u79cd\u53d8\u4f53\u6765\u505a\u5230\u8fd9\u4e00\u70b9\u3002<\/p>\n

\u8be5\u516c\u53f8\u7ba1\u7406\u5c42\u62a5\u544a\uff0c6\u6708\u5f53\u5b63\u8425\u6536\u98d9\u5347278%\uff0c\u81f3470\u4e07\u6fb3\u5143\uff0c\u5e76\u79f0\u5bf9\u65b0\u51a0\u68c0\u6d4b\u7684\u9700\u6c42\u662f\u589e\u957f\u7684\u4e00\u4e2a\u63a8\u52a8\u529b\u3002<\/p>\n

\u7ecf\u7eaa\u516c\u53f8Bell Potter\u6307\u51fa\uff0c2018\u5e74\u5168\u7403\u5206\u5b50\u8bca\u65ad\u5e02\u573a\u4ef7\u503c\u8d85\u8fc760\u4ebf\u7f8e\u5143(84\u4ebf\u6fb3\u5143)\uff0c\u9884\u8ba1\u52302026\u5e74\u5c06\u589e\u957f\u5230100\u4ebf\u6fb3\u5143\u3002<\/p>\n

\u8be5\u884c\u4e1a\u4e5f\u4e00\u76f4\u662f\u5e76\u8d2d\u7684\u6e29\u5e8a\uff0c\u6bd4\u5982\u6700\u8fd1Thermo Fisher\u4ee5115\u4ebf\u7f8e\u5143\u6536\u8d2d\u8377\u5170\u8bca\u65ad\u96c6\u56e2Qiagen\uff0c\u4ee5\u53caDanaher Corp\u57282018\u5e74\u4ee540\u4ebf\u7f8e\u5143\u6536\u8d2d\u7f8e\u56fd\u8bca\u65ad\u96c6\u56e2Cepheid\u3002<\/p>\n

Bell Potter\u8868\u793a:\u201c\u6211\u4eec\u9884\u8ba1\uff0c\u8be5\u9886\u57df\u7684\u5e76\u8d2d\u6d3b\u52a8\u5c06\u7ee7\u7eed\u8fdb\u884c\u3002\u968f\u7740\u57fa\u56e0\u7b7e\u540d\u8fdb\u4e00\u6b65\u5411\u5173\u952e\u7684\u7f8e\u56fd\u548c\u6b27\u6d32\u5e02\u573a\u6269\u5f20\uff0c\u4ee5\u53ca\u4ea7\u54c1\u5957\u4ef6\u7684\u589e\u957f\uff0c\u8be5\u516c\u53f8\u5728\u6218\u7565\u4e0a\u5904\u4e8e\u6709\u5229\u5730\u4f4d\uff0c\u5c06\u5438\u5f15\u6295\u8d44\u8005\u7684\u5174\u8da3\u3002\u201d<\/p>\n

\u5e72\u7ec6\u80de\u6cbb\u7597<\/h2>\n

\u867d\u7136Genetic Signatures\u662f\u589e\u52a0\u6536\u5165\u7684\u4e00\u4e2a\u4f8b\u5b50\uff0c\u4f46\u5e72\u7ec6\u80de\u5f00\u53d1\u5546Mesoblast (ASX: MSB)<\/a>\u6b63\u5904\u4e8e\u516c\u53f8\u6fc0\u52a8\u4eba\u5fc3\u7684\u516c\u544a\u9636\u6bb5\uff0c\u6d89\u53ca\u51e0\u4e2a\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u671f\u671b\u7f8e\u56fd\u6279\u51c6\u5176\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(\u79fb\u690d\u60a3\u8005\u5e38\u89c1\u7684\u75be\u75c5)\u7684\u65b9\u6848\u3002<\/p>\n

\u81ea\u7136\uff0c\u5927\u591a\u6570\u6295\u8d44\u8005\u5173\u6ce8\u7684\u662f\u51a0\u72b6\u75c5\u6bd2\u8bd5\u9a8c\uff0c\u5176\u4e2d\u5305\u62ec\u4f7f\u7528\u73b0\u6210\u7597\u6cd5remestemcel-L(\u54c1\u724c\u4e3aRyoncil)\u6cbb\u7597\u91cd\u75c7\u62a4\u7406\u60a3\u8005\u3002<\/p>\n

\u5927\u591a\u6570\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u8005\u6b7b\u4e8e\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\uff0c\u8fd9\u662f\u4e00\u79cd\u7531\u514d\u75ab\u7cfb\u7edf\u5bf9\u75c5\u6bd2\u7684\u53cd\u5e94\u5f15\u8d77\u7684\u708e\u75c7\u72b6\u6001\u3002<\/p>\n

Mesoblast\u7684\u76ee\u6807\u662f\u5728\u7f8e\u56fd30\u5bb6\u533b\u9662\u767b\u8bb0300\u540d\u60a3\u8005\u2014\u2014\u8003\u8651\u5230\u75be\u75c5\u7684\u4e2d\u5fc3\u6b63\u5728\u4ece\u4e00\u4e2a\u5730\u533a\u8f6c\u79fb\u5230\u53e6\u4e00\u4e2a\u5730\u533a\uff0c\u8fd9\u662f\u4e00\u4e2a\u4e0d\u65ad\u79fb\u52a8\u7684\u76ee\u6807\u3002<\/p>\n

\u5c3d\u7ba1\u5982\u6b64\uff0c\u7b2c\u4e00\u6279\u60a3\u8005\u57285\u6708\u4efd\u63a5\u53d7\u4e86\u836f\u7269\u6cbb\u7597\uff0c\u5728\u81f3\u5c1130%\u7684\u60a3\u8005\u5df2\u7ecf\u63a5\u53d7\u4e8630\u5929\u6cbb\u7597\u540e\uff0c\u9700\u8981\u8fdb\u884c\u4e2d\u671f\u5206\u6790\u3002<\/p>\n

\u6362\u53e5\u8bdd\u8bf4\uff0c\u6295\u8d44\u8005\u5f88\u5feb\u5c31\u4f1a\u77e5\u9053\u8be5\u516c\u53f8\u662f\u5426\u6b63\u5904\u4e8e\u91cd\u5927\u6cbb\u7597\u7a81\u7834\u7684\u98ce\u53e3\u4e0a\u3002<\/p>\n

\u5982\u679c\u8fd9\u8fd8\u4e0d\u591f\u4ee4\u4eba\u5174\u594b\uff0cMesoblast\u9884\u8ba1\u5c06\u516c\u5e03\u4e24\u9879III\u671f\u7814\u7a76\u7684\u7ed3\u679c:\u4e00\u9879\u6709566\u540d\u60a3\u8005\u53c2\u4e0e\u7684\u6162\u6027\u5fc3\u529b\u8870\u7aed\u7814\u7a76\u548c\u4e00\u9879\u6709404\u540d\u60a3\u8005\u53c2\u4e0e\u7684\u7531\u690e\u95f4\u76d8\u9000\u53d8\u5f15\u8d77\u7684\u6162\u6027\u8170\u75db\u7814\u7a76\u3002<\/p>\n

\u5728\u5e72\u7ec6\u80de\u9886\u57df\uff0cCynata Therapeutics (ASX: CYP)<\/a>\u6b63\u8ba1\u5212\u5f00\u5c55\u81ea\u5df1\u7684\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0d\u4ec5\u4e0eARDS\u6709\u5173\uff0c\u8fd8\u4e0e\u8d25\u8840\u75c7\u548c\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81(\u65b0\u51a0\u6b7b\u4ea1\u7684\u6240\u6709\u539f\u56e0)\u6709\u5173\u3002<\/p>\n

\u8be5\u516c\u53f8\u53d7\u5230\u4e34\u5e8a\u524d\u5efa\u6a21\u7684\u9f13\u821e\uff0c\u5e76\u5df2\u83b7\u5f97\u76d1\u7ba1\u90e8\u95e8\u6279\u51c6\u8fdb\u884c\u8bd5\u9a8c\u3002<\/p>\n

Cynata\u539f\u672c\u8ba1\u5212\u5728\u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u62db\u52df24\u540d\u91cd\u75c7\u60a3\u8005\uff0c\u4f46\u6216\u8bb8\u5b83\u5e94\u8be5\u91cd\u65b0\u5173\u6ce8\u9ed8\u91cc\u6cb3\u4ee5\u5357\u7684\u5730\u533a\u3002<\/p>\n

Cynata\u7684\u9996\u5e2d\u6267\u884c\u5b98Ross Macdonald\u5728\u7ef4\u591a\u5229\u4e9a\u65f6\u671f\u7684\u75ab\u60c5\u590d\u82cf\u524d\u8bf4:\u201c\u5f88\u660e\u663e\uff0c\u6fb3\u5927\u5229\u4e9a\u7684\u9884\u9632\u63aa\u65bd\u6709\u6548\u5730\u5c06\u8fd9\u4e00\u66f2\u7ebf\u62c9\u5e73\u4e86\uff0c\u6211\u4eec\u5f88\u5feb\u5c31\u7528\u5149\u4e86\u53ef\u7528\u7684\u75c5\u4eba\u3002\u201d<\/p>\n

\u89e3\u51b3\u51a0\u72b6\u75c5\u6bd2\u6b7b\u4ea1\u539f\u56e0\u662f\u4e00\u56de\u4e8b\uff0c\u4f46\u5982\u679c\u9664\u4e86\u5e74\u9f84\u548c\u5fc3\u810f\u75c5\u3001\u7cd6\u5c3f\u75c5\u7b49\u5171\u75c5\u7b49\u4e34\u5e8a\u56e0\u7d20\u5916\uff0c\u8fd8\u80fd\u66f4\u51c6\u786e\u5730\u9884\u6d4b\u611f\u67d3\u8fd9\u4e9b\u75be\u75c5\u7684\u98ce\u9669\uff0c\u90a3\u53c8\u5982\u4f55\u5462?<\/p>\n

\u8fd9\u6837\uff0c\u50cf\u7ef4\u591a\u5229\u4e9a\u8fd9\u6837\u88ab\u5c01\u9501\u5730\u533a\u7684\u5c45\u6c11\u5c31\u53ef\u4ee5\u629b\u5f03\u4ed6\u4eec\u7684\u53e3\u7f69\uff0c\u6446\u8131\u5b64\u7acb\u3002<\/p>\n

\u53e6\u4e00\u4e2a\u6f5c\u5728\u7684\u6cbb\u7597<\/h2>\n

\u4e0e\u6b64\u540c\u65f6\uff0c\u80be\u810f\u75be\u75c5\u516c\u53f8Dimerix (ASX: DXB)<\/a>\u7684\u80a1\u4ef7\u4e0a\u5468\u98d9\u5347\uff0c\u539f\u56e0\u662f\u4e00\u79cd\u540d\u4e3a\u5c40\u7076\u8282\u6bb5\u6027\u80be\u5c0f\u7403\u786c\u5316(FSGS)\u7684\u7f55\u89c1\u75be\u75c5\u7684\u4e34\u5e8a\u7ed3\u679c\u5448\u9633\u6027\u3002<\/p>\n

\u4f46\u662f\u5019\u9009\u836f\u7269DMX-200\u4e5f\u88ab\u9009\u4e3a\u6cbb\u7597ARDS\u7684\u5168\u7403\u8bd5\u9a8c\u7684\u8bc4\u4f30\u836f\u7269\uff0cARDS\u548cFSGS\u7684\u5171\u540c\u56e0\u7d20\u662f\u7ea4\u7ef4\u5316\u3002<\/p>\n

\u8fd9\u9879\u7531\u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u652f\u6301\u7684\u8bd5\u9a8c\uff0c\u7b80\u79f0REMAP-CAP\uff0c\u76ee\u6807\u662f\u5728200\u591a\u4e2a\u7f51\u7ad9\u62db\u52df7000\u540d\u60a3\u8005\u3002<\/p>\n

DMX-200\u662f\u4f17\u591a\u6b63\u5728\u7814\u7a76\u7684\u6f5c\u5728\u7597\u6cd5\u4e4b\u4e00\uff0c\u4f46\u5bf9Dimerix\u6765\u8bf4\uff0c\u7f8e\u5999\u4e4b\u5904\u5728\u4e8e\uff0c\u8bd5\u9a8c\u8d39\u7528\u7531\u8d44\u52a9REMAP-CAP\u7684\u653f\u5e9c\u652f\u4ed8\u3002<\/p>\n

\u4f4f\u9662\u98ce\u9669\u65b0\u51a0\u57fa\u56e0\u5206\u6790\u6d4b\u8bd5<\/h2>\n

\u5206\u5b50\u8bca\u65ad\u673a\u6784Genetic Technologies (ASX: GTG)<\/a> \u6539\u53d8\u4e86\u7b56\u7565\uff0c\u7533\u8bf7\u4e86\u4e00\u9879\u57fa\u4e8e\u9057\u4f20\u5b66\u7684\u65b0\u51a0\u75c5\u6bd2\u53d1\u5c55\u98ce\u9669\u8bc4\u4f30\u7684\u4e34\u65f6\u4e13\u5229\u3002<\/p>\n

\u6839\u636e\u6765\u81ea1500\u540d\u65b0\u51a0\u75c5\u6bd2\u60a3\u8005\u7684\u7b2c\u4e09\u65b9\u57fa\u56e0\u7ec4\u6570\u636e\uff0c\u8be5\u516c\u53f8\u6253\u7b97\u5f00\u53d1\u4e00\u79cd\u539f\u578b\u6a21\u578b\uff0c\u4ee5\u8bc6\u522b\u4e00\u65e6\u611f\u67d3\u8be5\u75be\u75c5\u6700\u6709\u53ef\u80fd\u9700\u8981\u4f4f\u9662\u6cbb\u7597\u7684\u60a3\u8005\u3002<\/p>\n

\u5982\u679c\u75ab\u82d7\u5236\u6210\uff0cGenetic Technologies\u53ef\u4ee5\u5e2e\u52a9\u4f18\u5148\u786e\u5b9a\u8c01\u5148\u63a5\u79cd\u3002<\/p>\n

\u8fc4\u4eca\u4e3a\u6b62\uff0c\u57fa\u56e0\u6280\u672f\u4ee5\u5176\u4e73\u817a\u764c\u9884\u6d4b\u8bd5\u5242\u76d2\u800c\u95fb\u540d\uff0c\u4f46\u5b83\u7684\u8868\u73b0\u4ece\u672a\u4e0e\u5176\u627f\u8bfa\u76f8\u7b26\u3002<\/p>\n

\u4f46\u7f8e\u56fd\u6295\u8d44\u8005\u4e00\u76f4\u613f\u610f\u652f\u6301\u8be5\u516c\u53f8\u7684\u80a1\u7968\uff0c\u8be5\u516c\u53f8\u901a\u8fc7\u5728\u7eb3\u65af\u8fbe\u514b\u4e0a\u5e02\u52df\u96c6\u4e86510\u4e07\u7f8e\u5143(720\u4e07\u6fb3\u5143)\u7684\u8d44\u91d1\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002 \u81ea\u7136\u5730\uff0c\u90a3\u4e9b\u4e0e\u6297\u51fb\u6216\u68c0\u6d4b\u75c5\u6bd2(\u4e0d\u7ba1\u662f\u5047\u7684\u8fd8\u662f\u5047\u7684)\u6709\u5173\u7684\u751f\u7269\u6280\u672f\u516c\u53f8\u7684\u4f30\u503c\u98d9\u5347\u3002 \u6295\u8d44\u8005\u7684\u5174\u8da3\u5e76\u4e0d\u5c40\u9650\u4e8e\u201c\u65b0\u51a0\u96c6\u7fa4\u201d\uff0c\u8be5\u884c\u4e1a\u7684\u878d\u8d44\u83b7\u5f97\u4e86\u5168\u9762\u652f\u6301\u3002 \u8bca\u65ad\u6d4b\u8bd5\u5e02\u573a \u5728\u8bc4\u4f30\u65b9\u9762\uff0c\u4e00\u4e2a\u503c\u5f97\u6ce8\u610f\u7684\u8d62\u5bb6\u662fGenetic Signatures (ASX: GSS)\uff0c\u8be5\u516c\u53f8\u9500\u552e\u9488\u5bf9\u7ec6\u83cc\u548c\u75c5\u6bd2\u72b6\u51b5\u7684\u5206\u5b50\u8bca\u65ad\u6d4b\u8bd5\uff0c\u5305\u62ec\u8d85\u7ea7\u7ec6\u83cc\u3001\u6027\u4f20\u64ad\u75be\u75c5\u548c\u8bfa\u5982\u75c5\u6bd2(\u5728\u51a0\u72b6\u75c5\u6bd2\u767b\u4e0a\u90ae\u8f6e\u4e4b\u524d\uff0c\u8bfa\u5982\u75c5\u6bd2\u662f\u90ae\u8f6e\u4e0a\u7684\u5934\u53f7\u761f\u75ab)\u3002 \u8fd9\u79cd\u8bd5\u5242\u76d2\u4ee5Easyscreen\u54c1\u724c\u51fa\u552e\uff0c\u53ef\u4ee5\u5728\u5927\u91cf\u60c5\u51b5\u4e0b\u8fdb\u884c\u5feb\u901f\u3001\u51c6\u786e\u7684\u68c0\u6d4b\u3002\u8fd9\u4e9b\u6d4b\u8bd5\u83b7\u53d6\u76ee\u6807\u751f\u7269\u7684\u9057\u4f20\u4fe1\u606f\uff0c\u5e76\u6539\u53d8\u57fa\u56e0\u5e8f\u5217\u4ee5\u51cf\u5c11\u53d8\u91cf\u7684\u6570\u91cf\u3002 \u800c\u4e14\uff0c\u662f\u7684\uff0c\u8be5\u516c\u53f8\u4e5f\u662f\u4e00\u4e2a\u65b0\u51a0\u7684\u6545\u4e8b\u3002\u5728\u75ab\u60c5\u7206\u53d1\u4e4b\u524d\uff0c\u8be5\u516c\u53f8\u7684Easyscreen\u6d4b\u8bd5\u65e0\u6cd5\u533a\u5206SARS-cov-2(\u5bfc\u81f4\u65b0\u51a0\u75c5\u6bd2\u7684\u75c5\u6bd2)\u548c\u4e25\u91cd\u6025\u6027\u547c\u5438\u7cfb\u7edf\u7efc\u5408\u75c7(SARS)\uff0c\u4f46\u8be5\u516c\u53f8\u5df2\u7ecf\u8bbe\u8ba1\u4e86\u4e00\u79cd\u53d8\u4f53\u6765\u505a\u5230\u8fd9\u4e00\u70b9\u3002 \u8be5\u516c\u53f8\u7ba1\u7406\u5c42\u62a5\u544a\uff0c6\u6708\u5f53\u5b63\u8425\u6536\u98d9\u5347278%\uff0c\u81f3470\u4e07\u6fb3\u5143\uff0c\u5e76\u79f0\u5bf9\u65b0\u51a0\u68c0\u6d4b\u7684\u9700\u6c42\u662f\u589e\u957f\u7684\u4e00\u4e2a\u63a8\u52a8\u529b\u3002 \u7ecf\u7eaa\u516c\u53f8Bell Potter\u6307\u51fa\uff0c2018\u5e74\u5168\u7403\u5206\u5b50\u8bca\u65ad\u5e02\u573a\u4ef7\u503c\u8d85\u8fc760\u4ebf\u7f8e\u5143(84\u4ebf\u6fb3\u5143)\uff0c\u9884\u8ba1\u52302026\u5e74\u5c06\u589e\u957f\u5230100\u4ebf\u6fb3\u5143\u3002 \u8be5\u884c\u4e1a\u4e5f\u4e00\u76f4\u662f\u5e76\u8d2d\u7684\u6e29\u5e8a\uff0c\u6bd4\u5982\u6700\u8fd1Thermo Fisher\u4ee5115\u4ebf\u7f8e\u5143\u6536\u8d2d\u8377\u5170\u8bca\u65ad\u96c6\u56e2Qiagen\uff0c\u4ee5\u53caDanaher Corp\u57282018\u5e74\u4ee540\u4ebf\u7f8e\u5143\u6536\u8d2d\u7f8e\u56fd\u8bca\u65ad\u96c6\u56e2Cepheid\u3002 Bell Potter\u8868\u793a:\u201c\u6211\u4eec\u9884\u8ba1\uff0c\u8be5\u9886\u57df\u7684\u5e76\u8d2d\u6d3b\u52a8\u5c06\u7ee7\u7eed\u8fdb\u884c\u3002\u968f\u7740\u57fa\u56e0\u7b7e\u540d\u8fdb\u4e00\u6b65\u5411\u5173\u952e\u7684\u7f8e\u56fd\u548c\u6b27\u6d32\u5e02\u573a\u6269\u5f20\uff0c\u4ee5\u53ca\u4ea7\u54c1\u5957\u4ef6\u7684\u589e\u957f\uff0c\u8be5\u516c\u53f8\u5728\u6218\u7565\u4e0a\u5904\u4e8e\u6709\u5229\u5730\u4f4d\uff0c\u5c06\u5438\u5f15\u6295\u8d44\u8005\u7684\u5174\u8da3\u3002\u201d \u5e72\u7ec6\u80de\u6cbb\u7597 \u867d\u7136Genetic Signatures\u662f\u589e\u52a0\u6536\u5165\u7684\u4e00\u4e2a\u4f8b\u5b50\uff0c\u4f46\u5e72\u7ec6\u80de\u5f00\u53d1\u5546Mesoblast (ASX: MSB)\u6b63\u5904\u4e8e\u516c\u53f8\u6fc0\u52a8\u4eba\u5fc3\u7684\u516c\u544a\u9636\u6bb5\uff0c\u6d89\u53ca\u51e0\u4e2a\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u671f\u671b\u7f8e\u56fd\u6279\u51c6\u5176\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(\u79fb\u690d\u60a3\u8005\u5e38\u89c1\u7684\u75be\u75c5)\u7684\u65b9\u6848\u3002 \u81ea\u7136\uff0c\u5927\u591a\u6570\u6295\u8d44\u8005\u5173\u6ce8\u7684\u662f\u51a0\u72b6\u75c5\u6bd2\u8bd5\u9a8c\uff0c\u5176\u4e2d\u5305\u62ec\u4f7f\u7528\u73b0\u6210\u7597\u6cd5remestemcel-L(\u54c1\u724c\u4e3aRyoncil)\u6cbb\u7597\u91cd\u75c7\u62a4\u7406\u60a3\u8005\u3002 \u5927\u591a\u6570\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u8005\u6b7b\u4e8e\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\uff0c\u8fd9\u662f\u4e00\u79cd\u7531\u514d\u75ab\u7cfb\u7edf\u5bf9\u75c5\u6bd2\u7684\u53cd\u5e94\u5f15\u8d77\u7684\u708e\u75c7\u72b6\u6001\u3002 Mesoblast\u7684\u76ee\u6807\u662f\u5728\u7f8e\u56fd30\u5bb6\u533b\u9662\u767b\u8bb0300\u540d\u60a3\u8005\u2014\u2014\u8003\u8651\u5230\u75be\u75c5\u7684\u4e2d\u5fc3\u6b63\u5728\u4ece\u4e00\u4e2a\u5730\u533a\u8f6c\u79fb\u5230\u53e6\u4e00\u4e2a\u5730\u533a\uff0c\u8fd9\u662f\u4e00\u4e2a\u4e0d\u65ad\u79fb\u52a8\u7684\u76ee\u6807\u3002 \u5c3d\u7ba1\u5982\u6b64\uff0c\u7b2c\u4e00\u6279\u60a3\u8005\u57285\u6708\u4efd\u63a5\u53d7\u4e86\u836f\u7269\u6cbb\u7597\uff0c\u5728\u81f3\u5c1130%\u7684\u60a3\u8005\u5df2\u7ecf\u63a5\u53d7\u4e8630\u5929\u6cbb\u7597\u540e\uff0c\u9700\u8981\u8fdb\u884c\u4e2d\u671f\u5206\u6790\u3002 \u6362\u53e5\u8bdd\u8bf4\uff0c\u6295\u8d44\u8005\u5f88\u5feb\u5c31\u4f1a\u77e5\u9053\u8be5\u516c\u53f8\u662f\u5426\u6b63\u5904\u4e8e\u91cd\u5927\u6cbb\u7597\u7a81\u7834\u7684\u98ce\u53e3\u4e0a\u3002 \u5982\u679c\u8fd9\u8fd8\u4e0d\u591f\u4ee4\u4eba\u5174\u594b\uff0cMesoblast\u9884\u8ba1\u5c06\u516c\u5e03\u4e24\u9879III\u671f\u7814\u7a76\u7684\u7ed3\u679c:\u4e00\u9879\u6709566\u540d\u60a3\u8005\u53c2\u4e0e\u7684\u6162\u6027\u5fc3\u529b\u8870\u7aed\u7814\u7a76\u548c\u4e00\u9879\u6709404\u540d\u60a3\u8005\u53c2\u4e0e\u7684\u7531\u690e\u95f4\u76d8\u9000\u53d8\u5f15\u8d77\u7684\u6162\u6027\u8170\u75db\u7814\u7a76\u3002 \u5728\u5e72\u7ec6\u80de\u9886\u57df\uff0cCynata Therapeutics (ASX: CYP)\u6b63\u8ba1\u5212\u5f00\u5c55\u81ea\u5df1\u7684\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0d\u4ec5\u4e0eARDS\u6709\u5173\uff0c\u8fd8\u4e0e\u8d25\u8840\u75c7\u548c\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81(\u65b0\u51a0\u6b7b\u4ea1\u7684\u6240\u6709\u539f\u56e0)\u6709\u5173\u3002 \u8be5\u516c\u53f8\u53d7\u5230\u4e34\u5e8a\u524d\u5efa\u6a21\u7684\u9f13\u821e\uff0c\u5e76\u5df2\u83b7\u5f97\u76d1\u7ba1\u90e8\u95e8\u6279\u51c6\u8fdb\u884c\u8bd5\u9a8c\u3002 Cynata\u539f\u672c\u8ba1\u5212\u5728\u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u62db\u52df24\u540d\u91cd\u75c7\u60a3\u8005\uff0c\u4f46\u6216\u8bb8\u5b83\u5e94\u8be5\u91cd\u65b0\u5173\u6ce8\u9ed8\u91cc\u6cb3\u4ee5\u5357\u7684\u5730\u533a\u3002 Cynata\u7684\u9996\u5e2d\u6267\u884c\u5b98Ross Macdonald\u5728\u7ef4\u591a\u5229\u4e9a\u65f6\u671f\u7684\u75ab\u60c5\u590d\u82cf\u524d\u8bf4:\u201c\u5f88\u660e\u663e\uff0c\u6fb3\u5927\u5229\u4e9a\u7684\u9884\u9632\u63aa\u65bd\u6709\u6548\u5730\u5c06\u8fd9\u4e00\u66f2\u7ebf\u62c9\u5e73\u4e86\uff0c\u6211\u4eec\u5f88\u5feb\u5c31\u7528\u5149\u4e86\u53ef\u7528\u7684\u75c5\u4eba\u3002\u201d \u89e3\u51b3\u51a0\u72b6\u75c5\u6bd2\u6b7b\u4ea1\u539f\u56e0\u662f\u4e00\u56de\u4e8b\uff0c\u4f46\u5982\u679c\u9664\u4e86\u5e74\u9f84\u548c\u5fc3\u810f\u75c5\u3001\u7cd6\u5c3f\u75c5\u7b49\u5171\u75c5\u7b49\u4e34\u5e8a\u56e0\u7d20\u5916\uff0c\u8fd8\u80fd\u66f4\u51c6\u786e\u5730\u9884\u6d4b\u611f\u67d3\u8fd9\u4e9b\u75be\u75c5\u7684\u98ce\u9669\uff0c\u90a3\u53c8\u5982\u4f55\u5462? \u8fd9\u6837\uff0c\u50cf\u7ef4\u591a\u5229\u4e9a\u8fd9\u6837\u88ab\u5c01\u9501\u5730\u533a\u7684\u5c45\u6c11\u5c31\u53ef\u4ee5\u629b\u5f03\u4ed6\u4eec\u7684\u53e3\u7f69\uff0c\u6446\u8131\u5b64\u7acb\u3002 \u53e6\u4e00\u4e2a\u6f5c\u5728\u7684\u6cbb\u7597 \u4e0e\u6b64\u540c\u65f6\uff0c\u80be\u810f\u75be\u75c5\u516c\u53f8Dimerix (ASX: DXB)\u7684\u80a1\u4ef7\u4e0a\u5468\u98d9\u5347\uff0c\u539f\u56e0\u662f\u4e00\u79cd\u540d\u4e3a\u5c40\u7076\u8282\u6bb5\u6027\u80be\u5c0f\u7403\u786c\u5316(FSGS)\u7684\u7f55\u89c1\u75be\u75c5\u7684\u4e34\u5e8a\u7ed3\u679c\u5448\u9633\u6027\u3002 \u4f46\u662f\u5019\u9009\u836f\u7269DMX-200\u4e5f\u88ab\u9009\u4e3a\u6cbb\u7597ARDS\u7684\u5168\u7403\u8bd5\u9a8c\u7684\u8bc4\u4f30\u836f\u7269\uff0cARDS\u548cFSGS\u7684\u5171\u540c\u56e0\u7d20\u662f\u7ea4\u7ef4\u5316\u3002 \u8fd9\u9879\u7531\u4e16\u754c\u536b\u751f\u7ec4\u7ec7(WHO)\u652f\u6301\u7684\u8bd5\u9a8c\uff0c\u7b80\u79f0REMAP-CAP\uff0c\u76ee\u6807\u662f\u5728200\u591a\u4e2a\u7f51\u7ad9\u62db\u52df7000\u540d\u60a3\u8005\u3002 DMX-200\u662f\u4f17\u591a\u6b63\u5728\u7814\u7a76\u7684\u6f5c\u5728\u7597\u6cd5\u4e4b\u4e00\uff0c\u4f46\u5bf9Dimerix\u6765\u8bf4\uff0c\u7f8e\u5999\u4e4b\u5904\u5728\u4e8e\uff0c\u8bd5\u9a8c\u8d39\u7528\u7531\u8d44\u52a9REMAP-CAP\u7684\u653f\u5e9c\u652f\u4ed8\u3002 \u4f4f\u9662\u98ce\u9669\u65b0\u51a0\u57fa\u56e0\u5206\u6790\u6d4b\u8bd5 \u5206\u5b50\u8bca\u65ad\u673a\u6784Genetic Technologies (ASX: GTG) \u6539\u53d8\u4e86\u7b56\u7565\uff0c\u7533\u8bf7\u4e86\u4e00\u9879\u57fa\u4e8e\u9057\u4f20\u5b66\u7684\u65b0\u51a0\u75c5\u6bd2\u53d1\u5c55\u98ce\u9669\u8bc4\u4f30\u7684\u4e34\u65f6\u4e13\u5229\u3002 \u6839\u636e\u6765\u81ea1500\u540d\u65b0\u51a0\u75c5\u6bd2\u60a3\u8005\u7684\u7b2c\u4e09\u65b9\u57fa\u56e0\u7ec4\u6570\u636e\uff0c\u8be5\u516c\u53f8\u6253\u7b97\u5f00\u53d1\u4e00\u79cd\u539f\u578b\u6a21\u578b\uff0c\u4ee5\u8bc6\u522b\u4e00\u65e6\u611f\u67d3\u8be5\u75be\u75c5\u6700\u6709\u53ef\u80fd\u9700\u8981\u4f4f\u9662\u6cbb\u7597\u7684\u60a3\u8005\u3002 \u5982\u679c\u75ab\u82d7\u5236\u6210\uff0cGenetic Technologies\u53ef\u4ee5\u5e2e\u52a9\u4f18\u5148\u786e\u5b9a\u8c01\u5148\u63a5\u79cd\u3002… Continue reading ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca<\/span><\/a><\/p>\n","protected":false},"author":8,"featured_media":8918,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[230,316,68,138,95],"yoast_head":"\nASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca<\/title>\n<meta name=\"description\" content=\"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca\" \/>\n<meta property=\"og:description\" content=\"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-07T00:04:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:46:27+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/ASX-biotech-stocks-COVID-19-life-science.jpg\" \/>\n<meta name=\"author\" content=\"Tim Boreham\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca\" \/>\n<meta name=\"twitter:description\" content=\"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/ASX-biotech-stocks-COVID-19-life-science.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tim Boreham\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/\",\"name\":\"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-08-07T00:04:36+00:00\",\"dateModified\":\"2023-08-29T17:46:27+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/6419420325c66d2634ad4bc623482402\"},\"description\":\"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/6419420325c66d2634ad4bc623482402\",\"name\":\"Tim Boreham\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/850d8953e09b9ad926709e0eaf7c92e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/850d8953e09b9ad926709e0eaf7c92e1?s=96&d=mm&r=g\",\"caption\":\"Tim Boreham\"},\"description\":\"Tim Boreham is a business journalist with 35 years experience, including more than two decades at The Australian and previously the Business Review Weekly magazine.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca","description":"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca","og_description":"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/","og_site_name":"smallcapsCN","article_published_time":"2020-08-07T00:04:36+00:00","article_modified_time":"2023-08-29T17:46:27+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/ASX-biotech-stocks-COVID-19-life-science.jpg"}],"author":"Tim Boreham","twitter_card":"summary_large_image","twitter_title":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca","twitter_description":"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/ASX-biotech-stocks-COVID-19-life-science.jpg","twitter_misc":{"Written by":"Tim Boreham"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/","url":"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/","name":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-08-07T00:04:36+00:00","dateModified":"2023-08-29T17:46:27+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/6419420325c66d2634ad4bc623482402"},"description":"\u5728\u5e02\u573a\u4e0d\u786e\u5b9a\u7684\u65f6\u5019\uff0c\u6295\u8d44\u8005\u901a\u5e38\u4f1a\u907f\u5f00\u6295\u673a\u6027\u6295\u8d44\uff0c\u4f46\u5728\u6fb3\u5927\u5229\u4e9a\u8bc1\u4ea4\u6240\u4e0a\u5e02\u7684\u836f\u7269\u3001\u8bca\u65ad\u548c\u8bbe\u5907\u7c7b\u80a1\u7684\u60c5\u51b5\u5e76\u975e\u5982\u6b64\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/asx-biotech-stocks-benefiting-from-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"ASX\u751f\u7269\u79d1\u6280\u80a1\u56e0\u75ab\u60c5\u800c\u53d7\u76ca"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/6419420325c66d2634ad4bc623482402","name":"Tim Boreham","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/850d8953e09b9ad926709e0eaf7c92e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/850d8953e09b9ad926709e0eaf7c92e1?s=96&d=mm&r=g","caption":"Tim Boreham"},"description":"Tim Boreham is a business journalist with 35 years experience, including more than two decades at The Australian and previously the Business Review Weekly magazine.","url":"https:\/\/smallcapscn.x5view.co\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1710"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1710"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1710\/revisions"}],"predecessor-version":[{"id":8917,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1710\/revisions\/8917"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8918"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}